Zynex NMES for Post-Operative ACL Rehabilitation
Zynex NexWave Electrotherapy Device
Anterior Cruciate Ligament Injuries+10
+ Asthenia
+ Atrophy
Treatment Study
Summary
Study start date: November 1, 2025
Actual date on which the first participant was enrolled.This study explores the benefits of using Zynex Neuromuscular Electrical Stimulation (NMES) alongside regular rehabilitation for patients recovering from anterior cruciate ligament reconstruction (ACLR) surgery. The goal is to see if NMES can help improve knee movement, muscle strength, and walking abilities more effectively than standard rehabilitation alone. By understanding these effects, the study aims to offer better recovery options for people undergoing ACLR, potentially leading to quicker and more balanced recovery. Participants in the study will follow a typical ACLR rehabilitation program, but some will also use the NMES device. This device is applied to the muscles and sends electrical impulses to stimulate them, which may enhance muscle strength and movement. The study will compare muscle strength and movement symmetry before and after surgery in those using NMES and those who are not, to see if the NMES group shows better outcomes. This approach will help determine if adding NMES to standard rehab truly offers additional benefits.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.25 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 15 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * ACLR surgical patients at KUMC sports medicine * 15 to 50 years old * BMI between 18 - 30 kg/m2 * No limitations impacting physical function within the last 6 months (not including the ACL injury) Exclusion Criteria: * Previous lower limb or spine injury involving surgical treatment * Prior spine surgery * Lower limb injury (other than ACL) preventing participation in physical activity for over two weeks in the past 6 months * Non english speaking * Vulnerable population, prisoner, or ward of the state
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location